Through the detection of testosterone concentration and aromatase mRNA and protein levels in PCOS patients, researchers have found that high testosterone levels in the ovarian environment can inhibit the expression of aromatase; this enriches aromatase and androgen’s mechanism of action [152]. The gene discussed is CYP19A1; the disease is polycystic ovary syndrome.